Q1 2021 Holdings
Filed 2021-05-17 | 85 holdings | $553.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $266.0M | 764,188 | 48.1% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $58.5M | 2,084,883 | 10.6% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $48.9M | 2,014,858 | 8.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $48.8M | 2,100,000 | 8.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $47.1M | 170,926 | 8.5% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $44.8M | 1,074,082 | 8.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $18.9M | 250,000 | 3.4% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $17.8M | 1,603,361 | 3.2% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $342.6K | 2,000,000 | 0.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $159.9K | 3,484,264 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $152.7K | 2,075,905 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $148.5K | 4,345,016 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $81.9K | 1,094,000 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $74.6K | 2,268,236 | 0.0% |
| Silverback Therapeutics Inc(SPRY) | COM | 82835W108 | $73.1K | 1,675,377 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $65.0K | 1,466,051 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $55.5K | 400,000 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $51.8K | 2,202,812 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $51.2K | 2,287,782 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $45.4K | 4,341,009 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $44.7K | 1,294,132 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $40.2K | 7,534,598 | 0.0% |
| Merus N V | COM | N5749R100 | $39.7K | 1,900,000 | 0.0% |
| Connect Biopharma Hlds LTD | ADS | 207523101 | $38.5K | 2,081,323 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $38.1K | 1,224,892 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $37.3K | 6,000,000 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $37.2K | 2,400,000 | 0.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $34.9K | 686,347 | 0.0% |
| Aligos Therapeutics Inc | COM | 01626L105 | $34.7K | 1,526,048 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $33.8K | 2,202,333 | 0.0% |
| Passage BIO Inc | COM | 702712100 | $33.7K | 1,928,315 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $33.2K | 1,065,939 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $29.7K | 1,050,289 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $28.0K | 1,300,000 | 0.0% |
| Direxion SHS ETF TR(LABDUSD) | DAILY S&P BIOTEC | 25460G716 | $27.2K | 1,250,000 | 0.0% |
| Achilles Therapeutics PLC(698) | SPONSORED ADS | 00449L102 | $25.4K | 1,536,208 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $24.5K | 1,121,327 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $24.1K | 6,205,882 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $24.1K | 831,495 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $23.7K | 2,562,358 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $23.4K | 4,234,574 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $23.0K | 2,325,000 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $21.0K | 6,226,673 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $20.0K | 687,000 | 0.0% |
| Talis Biomedical Corp | COM | 87424L108 | $19.9K | 1,550,998 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $19.2K | 5,607,086 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $18.5K | 1,501,058 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $18.2K | 4,000,000 | 0.0% |
| Gemini Therapeutics Inc | COM | 36870G105 | $17.6K | 1,300,000 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $16.0K | 1,000,000 | 0.0% |